chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient complained of Lightheadedness immediately after injection. Lightheadedness lasted 25 minutes. Symptom resolved. Patient left facility with family in stable condition.   Patient stated symptom was worse and lasted longer  with the first two vaccinations
Area of upper right arm feels painful, heavy and stiff, as if I just got the vaccine. I experienced the same symptoms with the first dose, but to a lesser degree. I have had these symptoms up to this very day.
Patient is an 89-year-old female with an extensive past medical history that includes but is not limited to hypertension, high cholesterol, type 2 diabetes and GERD who presents to the emergency department with complaint of shortness of breath and a positive test for COVID yesterday.  Patient is not the best historian is difficult to get information out of her she basically says she has been having trouble breathing off and on over the entire summer but she was getting worse a few days ago family had her take a COVID test at home and it came back positive.  Reports shortness of breath nonproductive cough wheezing and exertional dyspnea.  Nursing staff reports to me that the patient ambulating from her car to the hospital bed her oxygen saturation fell to 85%.  They placed her on supplemental O2 before my exam.  Patient denies any history of asthma or COPD but per nursing staff she has a nebulizer at home. Associated Symptoms: cough, fatigue, shortness of breath, URI symptoms, wheezing
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history or concurrent conditions was provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL, injection (lot # K016966, expiry date 10-MAY-2017 and lot # reported as L026034, expiry date 23-JUL-2017), exact dose and route of administration were not reported. There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a nurse refers to 4 patients of unknown age. The case was linked to case 1305USA017051 (same reporter link). On an unknown date the patients were vaccinated with VARIVAX (Merck) lot # H009841. The VARIVAX (Merck) had multiple excursions reaching the highest temperature of 15.5f. The nurse was unsure how many total hours of the excursions but reported that it was over 72 hours. No adverse effect was reported. Additional information has been requested.
dizzy; Sick; stiff; stomach sick; extreme weakness; back pain; lost weight; change in appetite; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick) and ASTHENIA (extreme weakness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick), ASTHENIA (extreme weakness), BACK PAIN (back pain), WEIGHT DECREASED (lost weight) and APPETITE DISORDER (change in appetite). At the time of the report, DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick), ASTHENIA (extreme weakness), BACK PAIN (back pain), WEIGHT DECREASED (lost weight) and APPETITE DISORDER (change in appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    Reporter did not allow further contact
Vaccinated with live attenuated intranasal H1N1 vaccine on 10/08/09. On 10/11/09 I developed runny nose, headache, and scratchy throat. Cough developed over next few days. On 10/16/09 I had subjective fever and anorexia. A close contact became ill on 10/19/09 (exposed 10/15-17/09). Cough persisted until 10/24/09. My concern is that I am a healthcare professional who transmitted infection after the vaccination.
Received Hep B & Polio shot on 11/08/2002. Fever soon rose to increase 105 degree F. ER required.
2 days after 2nd dose of pfizer vaccine, had systemic itching, and rash, and then blistering eruption of feet  2 months into this illness now the platelets are now lower- began from 160 not at 120, but he is not having any bleeding issues, rest of cbc is normal
Pulse increased; Feeling discomfort; Dizziness; Fever like symptoms/ aprox 37-38C; Fatigue; This is a spontaneous case, reported by other non-health professional (consumer) to Agency (Case ID: SEQ19-03067) and initially received on 23-Sep-2019, concerning a 33-year-old, adult, male patient.   The patient had no relevant medical history, drug reactions or allergies, and concomitant medications provided.  On 19-Sep-2019, the patient was administered Flucelvax QIV [influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route of administration: intramuscular (IM), anatomical location: arm, batch number, expiration date: not reported] for influenza prophylaxis.  On 23-Sep-2019, at 8 am, the patient developed a fever-like symptoms, approximately 37-38 C. Pulse increased and the patient felt discomfort, dizziness and fatigue. During night fever got to 38.1 C (106 F). Corrective treatment has not been applied yet.  On 24-Sep-2019 in the morning, the fever stopped, the patient had no more temperature.  On 26-Sep-2019, dizziness and sweating went away as reported.  On 29-Sep-2019, the patient was feeling fatigued.  On 30-Sep-2019, the patient was better than the day before. And reported he was 80% recovered.  The outcome of the events fever-like symptoms, approximately 37-38 C and dizziness was recovered on 26-Sep-2019.  The outcome of the events pulse increased, feeling discomfort and fatigue was recovering, at the time of this report.  The reporter assessed the case as non serious and did not provide causality assessment to Flucelvax.  Follow up received on 30-Sep-2019: It was provided the outcome and stop dates of the events. Dizziness was added. The narrative was amended accordingly.; Sender's Comments: The patient experienced heart rate increased, discomfort, dizziness, pyrexia and fatigue four days after receipt of Flucelvax QIV. Chronology is plausible. More information regarding medical history and concomitant drugs is needed. Based on provided information, causal role of the suspect product is assessed as related for all events.
Pt developed fever to 103 & rash which progressed 4/12 & persisted x 5-6 days. Unable to differentiate wild type measle, infection from adverse vaccine event.
The injection site had a round, red, & inflamed circle shape for two weeks after the injection. My right upper arm has not stopped hurting since receiving the shot. It hurts to the point of waking me up at night. I have not reported this to my physician as of yet, because I thought it would go away. I will now contact my physician to report the effects.
Pt received vaccine was being watched and at about 10 minutes pt stated that she was feeling light headed and very hot around her face, I asked about shortness of breath and chest pain she stated she did not have SOB but did have chest pain/tightness. She agreed for  EMS to come  which I called at 11:06 and they checked her out when they got here at 11:19 AM . She did not go with EMS.
2 different adult patients who received VARIVAX and PROQUAD; The patients were supposed receive MMR-II and VARIVAX.; This spontaneous report was received from a medical assistant via company representative, referring to an adult patient in the 30s-40s. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not provided.   On an unknown date, the patient was vaccinated once with varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) as prophylaxis (for both of them the strength, dose, routes of administration, vaccination scheme frequency, anatomical sites of vaccination, lot numbers, and expiration dates were not reported), instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) (product administered to patient of inappropriate age and wrong product administered).  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2010USA001734:
Started with a headache and cough about an hour after the injection (Monday). I woke up the next morning (Tuesday) at 5 AM with a fever of 102.2. I then proceeded to run a fever the rest of that day up to 104.4 although I was taking both Tylenol and Motrin alternating. I also had severe muscle aches and pain and very tired. On the next day (Wednesday) my fever did not get above 102 and finally got down to 99.6 about 6pm that evening. The body aches, tiredness and pain continued that day. On Thursday the low grade fever resolved and the body aches, pains and tiredness started to lessen. On Friday I felt like myself with just some minimal tiredness. The cough also continued throughout the post vaccine period and finally resolved on Sunday.
Patient appeared to have had suffered a stroke. Admitted to hospital, tests determined no stroke. Patient had pneumonia, and severe inflammatory response. Sepsis.
J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/24/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Patient called while in his car stating that his face is all red 1 hr after receiving FLUCELVAX.
Fatigue, chills and fever (which I was told about prior) lasting 24 hours but the continued body aches for 48 hours was horrible and injection spot was very swollen, raised and hot to touch
Pt devel fever 104 for first 16 hrs p/vax; Pulse reportedly 200 w/muscular twitching but no convuls;
This case was reported by a consumer (the subject's father) and described the occurrence of stomach pain in a 2-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. There were no concomitant medications and no relevant medical history. It was unknown whether the subject had experienced adverse events following previous vaccination. Previous and/or concurrent vaccination included PCV; manufacturer unspecified given on 19 October 2009; HIB; manufacturer unspecified given on 19 October 2009; DTAP; manufacturer unspecified given on 19 October 2009; HEP B; manufacturer unspecified given on 19 October 2009; IPV; manufacturer unspecified given on 19 October 2009. On 19 October 2009 the subject received 1st dose of ROTARIX (intramuscular, unknown thigh), and experienced inappropriate route of vaccination. On 26 October 2009, 7 days after vaccination with ROTARIX, the subject experienced stomach pain, watery bowel movements and fussiness. The reporter noted that since vaccination the subject may have stomach pain, as evidence by curling into a fetal position. He was also fussy and had watery bowel movements. The events started 1 week after ROTARIX administration. At the time of reporting the fussiness was unresolved, and the stomach pain and watery bowel movements were improved.
No additional AE/PQC; ROTATEQ was reported to have been administered post temperature excursion; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.   On 13-OCT-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot # 1684166, expiration date: 27-JUN-2021 (strength, dose, frequency and route of administration were unspecified) as prophylaxis. Administered dose of vaccine experienced the temperature excursion of 1.1 degree Celsius for 1 hour 23 minutes and 1.4 degree Celsius for 30 minutes. There was no previous excursion. The storage was not recorded by Digital Data Logger. There was no additional adverse event reported.   This is one of two reports from the same reporter (MARRS # 2012USA001305).; Sender's Comments:  US-009507513-2012USA001305:
I have "Covid Arm" that is prominent. Red rash at site of injection with a hard lump underneath.  When I received the vaccine a week ago, no reaction or discomfort at the site. Along with the redness, I experienced pain in my abdomen. That stopped.
When I woke on 4/22/2021 after receiving the shot on 4/21/2021 I couldn't stay awake I slept all day long only waking to go to bathroom and drink I slept through to 4/23/2021. Most concerning for me though was on 4/23/2021 the heat that radiate off my arm could be felt 10 inches away. On 4/24/2021 I developed a rash around injection site, and increasingly spread down my arm. On 4/26/2021 the rash started going up my arm to my shoulder and neck. The heat although not as hot spread with rash stopping at elbow and shoulder. The rash and heat lasted for 10 days before it started clear. The whole process took 3 to 3 and half weeks to clear completely. I know this is known as covid arm, however I am nervous about getting booster. Is it safe to get the booster? Should I get pfizer or stay with moderna? Or should I wait? That is my concern
Janssen COVID-19 Vaccine EUA  Fever onset 5 hours post-vaccination, lasting approximately 20 hours. Headache, chills, nausea and vomiting. Managed with acetaminophen and ibuprofen.
really bad pain in my thyroid gland; This spontaneous case was reported by a consumer and describes the occurrence of THYROID PAIN (really bad pain in my thyroid gland) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder (thyroid problems).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced THYROID PAIN (really bad pain in my thyroid gland). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, THYROID PAIN (really bad pain in my thyroid gland) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator
anaphylactic reaction; nose started running; throat started closing up; allergic reaction to Daptacel; Seriousness criteria: medically significant.   Initial information received on 18-Oct-2019 regarding an unsolicited valid serious case received from a consumer/non-hcp.  This case involves a 4 years old male patient who experienced anaphylactic reaction (anaphylactic reaction), while he received vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Food allergy.  On 18-Oct-2019, the patient received fourth dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a serious anaphylactic reaction, nose started running (rhinorrhoea), throat started closing up (throat tightness) and allergic reaction to daptacel (allergy to vaccine) (Unknown latency) following the administration of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE. This event was assessed as medically significant.  (Other relevant tests included no lab data.)  Final diagnosis was anaphylactic reaction.  It was not reported if the patient received a corrective treatment.  The patient was recovering from all the events.; Sender's Comments: This case concerns 4 years old male patient who experienced anaphylactic reaction after vaccination with DAPTACEL. The time to onset is unknown. Additional information regarding patient's past medical history, condition at the time of vaccination, lab investigation excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
itching at injection site; muscle soreness; This case was reported by a consumer via call center representative and described the occurrence of injection site itching in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th August 2022, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 9th August 2022, less than a day after receiving Shingrix, the patient experienced injection site itching and muscle soreness. On an unknown date, the outcome of the injection site itching was not recovered/not resolved and the outcome of the muscle soreness was recovered/resolved.   It was unknown if the reporter considered the injection site itching and muscle soreness to be related to Shingrix.     Additional Information: GSK Receipt Date: 12-Aug-2022 Reporter's comment: The patient did not want to give any demographics or further information.  The patient disconnected abruptly prior to being able to ask any further questions.  The patient received Shingrix vaccine in Right arm. The patient stated that after second dose of Shingrix vaccine, started with muscle soreness and itching at the injection site.  The patient stated that the muscle soreness was gone, but the itching was still present.  The patient did not consent to follow-up.  The patient did not consent for follow up with healthcare professional.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No concurrent or historical conditions were reported. On 21-DEC-2015, the patient was vaccinated with an improperly stored dose of ZOSTAVAX (Lot # L029482, expiration date 06-NOV-2016) dose, route and anatomical location were not provided. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Patient receive immunization in the left deltoid in the immunization clinic at 16:00. Patient presented to the ER the next day with cellulitis of left deltoid. Patient treated with Augmentin E.S. and released home.
This is a spontaneous report from a non-contactable consumer (patient).  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 02Feb2021 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported. The patient historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose administered in Right arm on 12Jan2021 for covid-19 immunisation. On 03Feb2021, the patient experienced Dizziness, sore arm, and low grade fever. No treatment was given. The outcome of the events was recovering.   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
LIMPING WITH LEFT HIP IN EXTERNAL ROTATION, NO FEVER, NORMAL crp
Child received immunizations in the afternoon. He was well that night. His mother had him seated in the infant seat. She heard him (questionable sound) sound stuffy and became dusky. No apnea. Dusky period probably less than 1-2 minutes. Admitted overnight for observation.  Discharge summary on 04/28/04 states: please take out "stiffening" and put in "sound stuffy". Patient went limp (hypotonia).
pt started loosing hair 6-8mo ago;hair loss has cont resulting in bald spots & loss is 1/2way up back of head;pvt MD told mom hair loss is due to HBV series;
Day of injection: Right arm pain (at injection site and throughout arm), right arm warmth, cold chills/shivers Day after injection: Right arm pain (at injection site and throughout arm), nausea, stomach cramping/pain, lower back aches
Pt is a female who was pregnant, estimated 7+ weeks gestation (LMP: 8/3/21, EDD:  5/10/22) when she received her COVID vaccine #1 on 23 SEP 21 following an appt with her PCM. She reported no significant events immediately following the vaccination. She reports soreness at the site of injection/left arm for one week. She reports having occasional mild abdominal cramping in the mornings, but did not think they were out of the ordinary. She otherwise felt well. On 15 OCT 21, she went to her scheduled initial OB appt. Both abdominal and vaginal ultrasounds were performed; no fetal movement or heartbeat was documented. The OB providers notified the pt of her miscarriage. Pt continues to follow up with OB for management.
Sore joints, muscles, sore rotator cuff, sore neck, fatigue, lasting 5+ days from time of vaccine sharp jaw pain on left side one day after vaccination, when eating a salad; jaw continued pain on chewing that day, with a clicking sound when jaw was opening/closing, and a feeling of an unstable joint; on 09/28/2019 sharp jaw pain again on left side, when eating raw broccoli; since then, unstable jaw joint has continued, but I am careful with what I eat and careful not to yawn or open my mouth wide, and not rest my chin in my hands, and other pointers found on the internet; I still have a sharp jaw joint pain once in awhile
Headache; fever; fatigue; chills; This case was reported by a consumer via call center representative and described the occurrence of headache in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On 1st June 2021, the patient received the 2nd dose of Shingrix. On 2nd June 2021, 1 days after receiving Shingrix, the patient experienced headache, fever, fatigue and chills. In June 2021, the outcome of the headache, fever, fatigue and chills were recovered/resolved.   It was unknown if the reporter considered the headache, fever, fatigue and chills to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported. The patient received 2nd dose of Shingrix vaccine and experienced fatigue, headache, fever, chills the next day but they resolved. The reporter did not consent to follow up.
Child developed red tender swelling of right upper arm 9pm 08/31/2005 with tactile fever. Exam on 08/31/2005 right upper arm 13 x 17cm erythematous, tender, swelling. Child started on Keflex and Benadryl oral.